[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583578":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":29,"centralContacts":33,"locations":38,"responsibleParty":54,"collaborators":10,"id":56,"slug":10,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":10,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":71,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8,14,17,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Group M",null,"Patients with mucormycosis undergo collection of blood, tissue and BAL fluid samples as well as have their medical records reviewed on study.",[13],"Behavioral: Mucormycosis",{"label":15,"type":10,"description":11,"interventionNames":16},"Group A",[13],{"label":18,"type":10,"description":11,"interventionNames":19},"Group B",[13],{"label":21,"type":10,"description":11,"interventionNames":22},"Group C",[13],[24],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"BEHAVIORAL","Mucormycosis","Tell the study team about any symptoms or side effects you have, follow study directions, and come to all study appointments (or contact the study team to reschedule).",[15,18,21,9],[30],{"name":31,"affiliation":5,"role":32},"Dimitrios Kontoyiannis, MD","PRINCIPAL_INVESTIGATOR",[34],{"name":31,"role":35,"phone":36,"phoneExt":10,"email":37},"CONTACT","(713) 792-0826","dkontoyi@mdanderson.org",[39],{"facility":40,"status":10,"city":41,"state":42,"zip":43,"country":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"MD Anderson Cancer Center","Houston","Texas","77030","United States",{"type":46,"coordinates":47},"Point",[48,49],-95.36327,29.76328,{"lat":49,"lon":48},[52],{"name":31,"role":35,"phone":53,"phoneExt":10,"email":37},"713-792-0826",{"type":55,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100583578",false,"NCT06878144","Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project","MD Anderson Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project (Deciphering Immunopathogenesis of MUCORmycosis to ADVANCE Risk Stratification, Diagnosis and Management of the Disease)","Inclusion Criteria:\n\n* Patients must be 18-100 years old and have cancer and invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection but no evidence of such infection.\n* Patients must be willing to undergo routine diagnostic procedures (e.g., phlebotomy, bronchoscopy, biopsy) as part of their regular care.\n\nExclusion Criteria:\n\n• Patients who are unwilling to undergo routine diagnostic procedures as part of their regular care.","ALL","18 Years","100 Years",{"count":66,"type":67},300,"ESTIMATED","OBSERVATIONAL","To collect data and samples from participants with cancer who also have invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection.",[26],"NOT_YET_RECRUITING","2025-09-05",{"date":74,"type":75},"2025-09-08","ACTUAL",{"date":77,"type":67},"2025-09-30",{"date":79,"type":67},"2032-12-31",{"name":5,"class":6},1]